Study marks breakthrough in IOP regulation in fight against glaucoma

April 5, 2012, Bascom Palmer Eye Institute

A six-year collaboration between two faculty members of Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has yielded new insight regarding the regulation of intraocular pressure (IOP) in glaucoma - an irreversible blinding disease that causes progressive visual impairment due to optic nerve damage and is the leading cause of blindness worldwide.

The key finding by associate professors of ophthalmology Richard K. Lee, M.D., Ph.D. and Sanjoy Bhattacharya, M. Tech., Ph, D. validates their hypothesis that the response of aqueous humor (fluid produced in the ) to at the cellular level (mechanosensing) impacts the regulation of IOP through cells converting that stimuli into chemical activity (mechanotransduction). At the center of this breakthrough lies the protein cochlin, which was discovered in the trabecular meshwork (TM) seven years ago using highly sensitive . The TM refers to tissue located around the base of the cornea that is responsible for filtering and draining aqueous humor from the eye and controlling the IOP. Mass spectrometry is a technique used to identify proteins and to determine their with great precision and can also ascertain if a protein has been modified. Bascom Palmer Eye Institute is one of only a few eye centers in the nation to have its own . In fact, two such cutting edge machines are now part of Bascom Palmer Eye Institute's Adrienne Arsht Hope for Vision Retinal Degeneration Research Laboratory, which was established with a $1 million gift from philanthropist Adrienne Arsht, given in 2008.

"With elevated IOP being the primary modifiable risk factor affecting the development and progression of ," said Lee, "This advancement opens up potential avenues for effective and innovative manipulation of the pathway of aqueous outflow using mechanosensors and mechanotransducers. In turn, it could lead to meaningful intervention strategies." Currently, the primary treatment for glaucoma is to lower IOP through the topical use of medications or eye surgery.

Additionally, Bhattacharya and Lee found that mechanosensing of fluid flow is transduced, or converted into chemical signals, by TREK-1 mechanotransducers on the cell surface. TREK -1 is a protein in the TM, but how it affects IOP was previously unknown. Also missing was an understanding of how cochlin works in mechanosensing. Lee and Bhattacharya's extensive research demonstrated that TREK 1 functions in conjunction with cochlin to regulate IOP.

Furthermore, Lee and Bhattacharya determined that aberrant levels of secreted cochlin disrupt aqueous outflow, thus allowing for a rise in IOP. "Fluctuations of IOP can alter cells of the trabecular meshwork," explained Bhattacharya. "This results in dysfunction of aqueous flow. Presently, there are over 2 million known proteins and 46,000 lipids that can be tested to determine their impact upon IOP."

Bhattacharya and Lee are already working on next steps using advanced mass spectrometry techniques. They hope to uncover endogenous and exogenous molecules that regulate aqueous humor outflow by modulating mechanosensors and mechanotransducers, "The success of this research is based on a strong, ongoing collaboration between Dr. Lee and myself, as well as hard work by postdoctoral fellows and graduate students," summarized Bhattacharya. "We are also fortunate that Bascom Palmer Eye Institute is one of the few vision research centers in the country to have two mass spectrometers. " Both Bhattacharya and Lee agree that without a mass spectrometer, and faculty members who have the expertise to use it to its full potential, this discovery would not have been possible. Funding for their research was received through the National Institutes of Health via two grants totaling $3.4 million.

Mass spectrometers are currently being used by other researchers at Bascom Palmer to identify mechanistic aspects of retinal degeneration and for unraveling mechanistic details of glaucoma pathology. "We continually learn from one another how mass spectrometry can lead to more exciting discoveries," said Bhattacharya. "It is a very valuable tool in the work to combat eye diseases."

On April 4, 2012, PLoS ONE, an open-access peer-reviewed scientific journal, produced by the Public Library of Science, published an article by Drs. Bhattacharya and Lee about this recent breakthrough. Click here to read the article.

Explore further: New research characterizes glaucoma as neurologic disorder rather than eye disease

Related Stories

New research characterizes glaucoma as neurologic disorder rather than eye disease

March 7, 2012
A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, ...

Research identifies risk factors associated with progression of glaucoma

May 9, 2011
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology.

British study may improve glaucoma assessment and treatment

October 24, 2011
Results from a recent scientific study in the U.K. may change the way that healthcare professionals measure eye pressure and allow them to assess the risk of glaucoma with greater accuracy. Glaucoma is the second most common ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.